Metabolomic prediction of treatment outcome in pancreatic ductal adenocarcinoma patients receiving gemcitabine.
作者:
主题词
腺癌(Adenocarcinoma);老年人(Aged);抗代谢药, 抗肿瘤(Antimetabolites, Antineoplastic);癌, 胰腺管(Carcinoma, Pancreatic Ductal);脱氧胞苷(Deoxycytidine);抗药性, 肿瘤(Drug Resistance, Neoplasm);平衡核苷转移子1(Equilibrative Nucleoside Transporter 1);女(雌)性(Female);气相色谱-质谱法(Gas Chromatography-Mass Spectrometry);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);乳酸(Lactic Acid);男(雄)性(Male);代谢组学(Metabolomics);中年人(Middle Aged);胰腺肿瘤(Pancreatic Neoplasms);ROC曲线(ROC Curve);回顾性研究(Retrospective Studies);存活率分析(Survival Analysis);治疗结果(Treatment Outcome)
DOI
10.1007/s00280-017-3475-6
PMID
29196965
发布时间
2022-12-07
- 浏览5
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文